
GC69997
TBI-166
Also known as 3-(4-methoxycyclohexyl)imino-N-(2-methoxy-3-pyridinyl)-5-[4-(trifluoromethoxy)phenyl]phenazin-2-amine
TBI-166, a riminophenazine analogue, is an orally active anti-tuberculosis molecule with fewer adverse effects than the Clofazimine compound
ChemicalCAS1353734-12-9MW589.61FormulaC32H30F3N5O3
- CAS number
- 1353734-12-9
- Molecular weight
- 589.61
- Formula
- C32H30F3N5O3
- Solubility
- DMSO : 9·09 mg/mL (15·42 mM; ultrasonic and adjust pH to 3 with HCl)
- InChIKey
- GUSGYHIQYWRCQO-UHFFFAOYSA-N
- Catalogue number
- GC69997
- Brand
- GLPBIO
Computed properties PubChem CID 53377576 · XLogP 6.6 · TPSA 80.6 Ų · H-bond donors 1
- XLogP
- 6.6
- TPSA
- 80.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 11
- Rotatable bonds
- 7
- Heavy atoms
- 43
SMILES COC1CCC(CC1)N=C2C=C3C(=NC4=CC=CC=C4N3C5=CC=C(C=C5)OC(F)(F)F)C=C2NC6=C(N=CC=C6)OC
Computed descriptors from PubChem (CID 53377576), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il